ShareValue scores for BAYERCROP.NSE: Valuation 27, Quality 64, Growth 49, Health 55.

Bayer Cropscience Limited logo

BAYERCROP.NSE
NSE

Bayer Cropscience Limited

₹4,302.90(+0.75%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-6% to 9%
Valuation
27
Overvalued
Price vs Value
Quality
64
Moderate
Business Strength
Growth
49
Moderate
Revenue & Earnings
Health
55
Moderate
Financial Stability
Momentum
44
Neutral
Price Trend

Company Details

About

Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and hybrid corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and computed tomography, X-Ray, and magnetic resonance imaging devices. In addition, the company offers consumer health products that are used as a daily health solution to treat minor illnesses, as well as sells and distributes row crop hybrid seeds. Further, it provides digital farming products comprising FarmRise and other digital applications, as well as tools, including remote sensing, IoT sensors, GPS, drones, artificial intelligence, and data analytics to monitor and manage crop growth, soil health, and weather conditions. The company also exports its products. Bayer CropScience Limited was founded in 1896 and is based in Thane, India.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026